{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:15:15Z","timestamp":1790882115089,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,28]]},"DOI":"10.7759\/cureus.27389","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T06:11:08Z","timestamp":1658988668000},"source":"Crossref","is-referenced-by-count":11,"title":["Ketamine and Its Emergence in the Field of Neurology"],"prefix":"10.7759","author":[{"given":"Luis","family":"Rueda Carrillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klepper Alfredo","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilufer","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manan","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"A study of a 1-aryl cyclo hexyl amine for anesthesia","volume":"37","author":"GR FE","year":"1958","unstructured":"GR FE, DE M, YO J, GA JE. A study of a 1-aryl cyclo hexyl amine for anesthesia. Anesth Analg. 1958, 37:283-94.","journal-title":"Anesth Analg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2016.00612","article-title":"Ketamine: 50 years of modulating the mind","volume":"10","author":"Li L","year":"2016","unstructured":"Li L, Vlisides PE. Ketamine: 50 years of modulating the mind. Front Hum Neurosci. 2016, 10:612. 10.3389\/fnhum.2016.00612","journal-title":"Front Hum Neurosci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cpt196563279","article-title":"Pharmacologic effects of CI-581, a new dissociative anesthetic, in man","volume":"6","author":"Domino EF","year":"1965","unstructured":"Domino EF, Chodoff P, Corssen G. Pharmacologic effects of CI-581, a new dissociative anesthetic, in man. Clin Pharmacol Ther. 1965, 6:279-91. 10.1002\/cpt196563279","journal-title":"Clin Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(99)00118-9","article-title":"The effects of a sub-anaesthetic dose of ketamine on human selective attention","volume":"22","author":"Oranje B","year":"2000","unstructured":"Oranje B, van Berckel BN, Kemner C, van Ree JM, Kahn RS, Verbaten MN. The effects of a sub-anaesthetic dose of ketamine on human selective attention. Neuropsychopharmacology. 2000, 22:293-302. 10.1016\/S0893-133X(99)00118-9","journal-title":"Neuropsychopharmacology"},{"key":"ref5","article-title":"Phencyclidine and ketamine intoxication: a study of four populations of recreational users","author":"Siegel RK","year":"1978","unstructured":"Siegel RK. Phencyclidine and ketamine intoxication: a study of four populations of recreational users. NIDA Res Monogr. 1978, 119-47.","journal-title":"NIDA Res Monogr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199704000-00021","article-title":"Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors","volume":"86","author":"Orser BA","year":"1997","unstructured":"Orser BA, Pennefather PS, MacDonald JF. Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology. 1997, 86:903-17. 10.1097\/00000542-199704000-00021","journal-title":"Anesthesiology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/749837","article-title":"Role of ketamine in acute postoperative pain management: a narrative review","volume":"2015","author":"Radvansky BM","year":"2015","unstructured":"Radvansky BM, Shah K, Parikh A, Sifonios AN, Le V, Eloy JD. Role of ketamine in acute postoperative pain management: a narrative review. Biomed Res Int. 2015, 2015:749837. 10.1155\/2015\/749837","journal-title":"Biomed Res Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2016.12.020","article-title":"(R)-ketamine shows greater potency and longer lasting antidepressant effects than its metabolite (2R,6R)-hydroxynorketamine","volume":"82","author":"Yang C","year":"2017","unstructured":"Yang C, Qu Y, Abe M, Nozawa D, Chaki S, Hashimoto K. (R)-ketamine shows greater potency and longer lasting antidepressant effects than its metabolite (2R,6R)-hydroxynorketamine. Biol Psychiatry. 2017, 82:e43-4. 10.1016\/j.biopsych.2016.12.020","journal-title":"Biol Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.599721","article-title":"Ketamine use for cancer and chronic pain management","volume":"11","author":"Culp C","year":"2020","unstructured":"Culp C, Kim HK, Abdi S. Ketamine use for cancer and chronic pain management. Front Pharmacol. 2020, 11:599721. 10.3389\/fphar.2020.599721","journal-title":"Front Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/da.22536","article-title":"A review of ketamine abuse and diversion","volume":"33","author":"Sassano-Higgins S","year":"2016","unstructured":"Sassano-Higgins S, Baron D, Juarez G, Esmaili N, Gold M. A review of ketamine abuse and diversion. Depress Anxiety. 2016, 33:718-27. 10.1002\/da.22536","journal-title":"Depress Anxiety"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/cns.12099","article-title":"Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings)","volume":"19","author":"Mion G","year":"2013","unstructured":"Mion G, Villevieille T. Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci Ther. 2013, 19:370-80. 10.1111\/cns.12099","journal-title":"CNS Neurosci Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2010.06.016","article-title":"Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain","volume":"15","author":"Dahan A","year":"2011","unstructured":"Dahan A, Olofsen E, Sigtermans M, et al.. Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain. Eur J Pain. 2011, 15:258-67. 10.1016\/j.ejpain.2010.06.016","journal-title":"Eur J Pain"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-197702050-00003","article-title":"Pharmacokinetics of intravenous anaesthetics: implications for clinical use","volume":"2","author":"Ghoneim MM","year":"1977","unstructured":"Ghoneim MM, Korttila K. Pharmacokinetics of intravenous anaesthetics: implications for clinical use. Clin Pharmacokinet. 1977, 2:344-72. 10.2165\/00003088-197702050-00003","journal-title":"Clin Pharmacokinet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-199811000-00039","article-title":"Ketamine: teaching an old drug new tricks","volume":"87","author":"Kohrs R","year":"1998","unstructured":"Kohrs R, Durieux ME. Ketamine: teaching an old drug new tricks. Anesth Analg. 1998, 87:1186-93. 10.1097\/00000539-199811000-00039","journal-title":"Anesth Analg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000001856","article-title":"In vogue: ketamine for neuroprotection in acute neurologic injury","volume":"124","author":"Bell JD","year":"2017","unstructured":"Bell JD. In vogue: ketamine for neuroprotection in acute neurologic injury. Anesth Analg. 2017, 124:1237-43. 10.1213\/ANE.0000000000001856","journal-title":"Anesth Analg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14676","article-title":"Starting ketamine for neuroprotection earlier than its current use as an anesthetic\/antiepileptic drug late in refractory status epilepticus","volume":"60","author":"Fujikawa DG","year":"2019","unstructured":"Fujikawa DG. Starting ketamine for neuroprotection earlier than its current use as an anesthetic\/antiepileptic drug late in refractory status epilepticus. Epilepsia. 2019, 60:373-80. 10.1111\/epi.14676","journal-title":"Epilepsia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-011-0582-3","article-title":"Inhibition of neuron-specific CREB dephosphorylation is involved in propofol and ketamine-induced neuroprotection against cerebral ischemic injuries of mice","volume":"37","author":"Shu L","year":"2012","unstructured":"Shu L, Li T, Han S, Ji F, Pan C, Zhang B, Li J. Inhibition of neuron-specific CREB dephosphorylation is involved in propofol and ketamine-induced neuroprotection against cerebral ischemic injuries of mice. Neurochem Res. 2012, 37:49-58. 10.1007\/s11064-011-0582-3","journal-title":"Neurochem Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.tacc.2014.03.002","article-title":"Ketamine - more mechanisms of action than just NMDA blockade","volume":"4","author":"Sleigh J","year":"2014","unstructured":"Sleigh J, Harvey M, Voss L, Denny B. Ketamine - more mechanisms of action than just NMDA blockade. Trends Anaesth Crit Care. 2014, 4:76-81. 10.1016\/j.tacc.2014.03.002","journal-title":"Trends Anaesth Crit Care"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2014.03.026","article-title":"Central antinociception induced by ketamine is mediated by endogenous opioids and \u03bc- and \u03b4-opioid receptors","volume":"1562","author":"Pacheco Dda F","year":"2014","unstructured":"Pacheco Dda F, Romero TR, Duarte ID. Central antinociception induced by ketamine is mediated by endogenous opioids and \u03bc- and \u03b4-opioid receptors. Brain Res. 2014, 1562:69-75. 10.1016\/j.brainres.2014.03.026","journal-title":"Brain Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-199507000-00012","article-title":"Inhibition by ketamine of muscarinic acetylcholine receptor function","volume":"81","author":"Durieux ME","year":"1995","unstructured":"Durieux ME. Inhibition by ketamine of muscarinic acetylcholine receptor function. Anesth Analg. 1995, 81:57-62. 10.1097\/00000539-199507000-00012","journal-title":"Anesth Analg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199803000-00029","article-title":"Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells","volume":"88","author":"Nishimura M","year":"1998","unstructured":"Nishimura M, Sato K, Okada T, Yoshiya I, Schloss P, Shimada S, Tohyama M. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells. Anesthesiology. 1998, 88:768-74. 10.1097\/00000542-199803000-00029","journal-title":"Anesthesiology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/57.2.197","article-title":"Comparative pharmacology of the ketamine isomers. Studies in volunteers","volume":"57","author":"White PF","year":"1985","unstructured":"White PF, Sch\u00fcttler J, Shafer A, Stanski DR, Horai Y, Trevor AJ. Comparative pharmacology of the ketamine isomers. Studies in volunteers. Br J Anaesth. 1985, 57:197-203. 10.1093\/bja\/57.2.197","journal-title":"Br J Anaesth"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1987.138","article-title":"Ketamine effects on local cerebral blood flow and metabolism in the rat","volume":"7","author":"Cavazzuti M","year":"1987","unstructured":"Cavazzuti M, Porro CA, Biral GP, Benassi C, Barbieri GC. Ketamine effects on local cerebral blood flow and metabolism in the rat. J Cereb Blood Flow Metab. 1987, 7:806-11. 10.1038\/jcbfm.1987.138","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/44.11.1200","article-title":"Ketamine anaesthesia in patients with intracranial pathology","volume":"44","author":"Shaprio HM","year":"1972","unstructured":"Shaprio HM, Wyte SR, Harris AB. Ketamine anaesthesia in patients with intracranial pathology. Br J Anaesth. 1972, 44:1200-4. 10.1093\/bja\/44.11.1200","journal-title":"Br J Anaesth"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/BF01808689","article-title":"The effect of ketamine on intracranial pressure during haemorrhagic shock under the conditions of both spontaneous breathing and controlled ventilation","volume":"78","author":"Pfenninger E","year":"1985","unstructured":"Pfenninger E, Gr\u00fcnert A, Bowdler I, Kilian J. The effect of ketamine on intracranial pressure during haemorrhagic shock under the conditions of both spontaneous breathing and controlled ventilation. Acta Neurochir (Wien). 1985, 78:113-8. 10.1007\/BF01808689","journal-title":"Acta Neurochir (Wien)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-013-9950-y","article-title":"The ketamine effect on ICP in traumatic brain injury","volume":"21","author":"Zeiler FA","year":"2014","unstructured":"Zeiler FA, Teitelbaum J, West M, Gillman LM. The ketamine effect on ICP in traumatic brain injury. Neurocrit Care. 2014, 21:163-73. 10.1007\/s12028-013-9950-y","journal-title":"Neurocrit Care"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000043073.69602.09","article-title":"Spreading and synchronous depressions of cortical activity in acutely injured human brain","volume":"33","author":"Strong AJ","year":"2002","unstructured":"Strong AJ, Fabricius M, Boutelle MG, et al.. Spreading and synchronous depressions of cortical activity in acutely injured human brain. Stroke. 2002, 33:2738-43. 10.1161\/01.str.0000043073.69602.09","journal-title":"Stroke"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws152","article-title":"Effect of analgesics and sedatives on the occurrence of spreading depolarizations accompanying acute brain injury","volume":"135","author":"Hertle DN","year":"2012","unstructured":"Hertle DN, Dreier JP, Woitzik J, et al.. Effect of analgesics and sedatives on the occurrence of spreading depolarizations accompanying acute brain injury. Brain. 2012, 135:2390-8. 10.1093\/brain\/aws152","journal-title":"Brain"},{"key":"ref29","article-title":"Exploration of NMDA receptors in migraine: therapeutic and theoretic implications","volume":"15","author":"Nicolodi M","year":"1995","unstructured":"Nicolodi M, Sicuteri F. Exploration of NMDA receptors in migraine: therapeutic and theoretic implications. Int J Clin Pharmacol Res. 1995, 15:181-9.","journal-title":"Int J Clin Pharmacol Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2018.8.37875","article-title":"Low-dose ketamine does not improve migraine in the emergency department: a randomized placebo-controlled trial","volume":"19","author":"Etchison AR","year":"2018","unstructured":"Etchison AR, Bos L, Ray M, et al.. Low-dose ketamine does not improve migraine in the emergency department: a randomized placebo-controlled trial. West J Emerg Med. 2018, 19:952-60. 10.5811\/westjem.2018.8.37875","journal-title":"West J Emerg Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/head.13013","article-title":"Ketamine infusions for treatment refractory headache","volume":"57","author":"Pomeroy JL","year":"2017","unstructured":"Pomeroy JL, Marmura MJ, Nahas SJ, Viscusi ER. Ketamine infusions for treatment refractory headache. Headache. 2017, 57:276-82. 10.1111\/head.13013","journal-title":"Headache"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00733.x","article-title":"Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model","volume":"160","author":"Chan KY","year":"2010","unstructured":"Chan KY, Gupta S, de Vries R, Danser AH, Villal\u00f3n CM, Mu\u00f1oz-Islas E, Maassenvandenbrink A. Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model. Br J Pharmacol. 2010, 160:1316-25. 10.1111\/j.1476-5381.2010.00733.x","journal-title":"Br J Pharmacol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-14-62","article-title":"Cortical spreading depression as a target for anti-migraine agents","volume":"14","author":"Costa C","year":"2013","unstructured":"Costa C, Tozzi A, Rainero I, Cupini LM, Calabresi P, Ayata C, Sarchielli P. Cortical spreading depression as a target for anti-migraine agents. J Headache Pain. 2013, 14:62. 10.1186\/1129-2377-14-62","journal-title":"J Headache Pain"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182824e66","article-title":"A randomized controlled trial of intranasal ketamine in migraine with prolonged aura","volume":"80","author":"Afridi SK","year":"2013","unstructured":"Afridi SK, Giffin NJ, Kaube H, Goadsby PJ. A randomized controlled trial of intranasal ketamine in migraine with prolonged aura. Neurology. 2013, 80:642-7. 10.1212\/WNL.0b013e3182824e66","journal-title":"Neurology"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9768949","article-title":"Updates in refractory status epilepticus","volume":"2018","author":"Marawar R","year":"2018","unstructured":"Marawar R, Basha M, Mahulikar A, Desai A, Suchdev K, Shah A. Updates in refractory status epilepticus. Crit Care Res Pract. 2018, 2018:9768949. 10.1155\/2018\/9768949","journal-title":"Crit Care Res Pract"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2016.12.044","article-title":"Pathophysiology of status epilepticus","volume":"667","author":"Walker MC","year":"2018","unstructured":"Walker MC. Pathophysiology of status epilepticus. Neurosci Lett. 2018, 667:84-91. 10.1016\/j.neulet.2016.12.044","journal-title":"Neurosci Lett"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12247","article-title":"Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study","volume":"54","author":"Gaspard N","year":"2013","unstructured":"Gaspard N, Foreman B, Judd LM, et al.. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia. 2013, 54:1498-503. 10.1111\/epi.12247","journal-title":"Epilepsia"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-018-0569-6","article-title":"Ketamine for refractory status epilepticus: a systematic review","volume":"32","author":"Rosati A","year":"2018","unstructured":"Rosati A, De Masi S, Guerrini R. Ketamine for refractory status epilepticus: a systematic review. CNS Drugs. 2018, 32:997-1009. 10.1007\/s40263-018-0569-6","journal-title":"CNS Drugs"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010611","article-title":"Ketamine to treat super-refractory status epilepticus","volume":"95","author":"Alkhachroum A","year":"2020","unstructured":"Alkhachroum A, Der-Nigoghossian CA, Mathews E, et al.. Ketamine to treat super-refractory status epilepticus. Neurology. 2020, 95:e2286-94. 10.1212\/WNL.0000000000010611","journal-title":"Neurology"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy GM","year":"2012","unstructured":"Brophy GM, Bell R, Claassen J, et al.. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012, 17:3-23. 10.1007\/s12028-012-9695-z","journal-title":"Neurocrit Care"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-020-00975-7","article-title":"Ketamine as an anesthetic for patients with acute brain injury: a systematic review","volume":"33","author":"Gregers MC","year":"2020","unstructured":"Gregers MC, Mikkelsen S, Lindvig KP, Br\u00f8chner AC. Ketamine as an anesthetic for patients with acute brain injury: a systematic review. Neurocrit Care. 2020, 33:273-82. 10.1007\/s12028-020-00975-7","journal-title":"Neurocrit Care"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03452-x","article-title":"Ketamine in acute phase of severe traumatic brain injury \"an old drug for new uses?\"","volume":"25","author":"Godoy DA","year":"2021","unstructured":"Godoy DA, Badenes R, Pelosi P, Robba C. Ketamine in acute phase of severe traumatic brain injury \"an old drug for new uses?\". Crit Care. 2021, 25:19. 10.1186\/s13054-020-03452-x","journal-title":"Crit Care"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2016.09.121","article-title":"Sedation of patients with acute aneurysmal subarachnoid hemorrhage with ketamine is safe and might influence the occurrence of cerebral infarctions associated with delayed cerebral ischemia","volume":"97","author":"Von der Brelie C","year":"2017","unstructured":"Von der Brelie C, Seifert M, Rot S, Tittel A, Sanft C, Meier U, Lemcke J. Sedation of patients with acute aneurysmal subarachnoid hemorrhage with ketamine is safe and might influence the occurrence of cerebral infarctions associated with delayed cerebral ischemia. World Neurosurg. 2017, 97:374-82. 10.1016\/j.wneu.2016.09.121","journal-title":"World Neurosurg"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.620468","article-title":"Preclinical evidence toward the use of ketamine for recombinant tissue-type plasminogen activator-mediated thrombolysis under anesthesia or sedation","volume":"42","author":"Gakuba C","year":"2011","unstructured":"Gakuba C, Gauberti M, Mazighi M, Defer G, Hanouz JL, Vivien D. Preclinical evidence toward the use of ketamine for recombinant tissue-type plasminogen activator-mediated thrombolysis under anesthesia or sedation. Stroke. 2011, 42:2947-9. 10.1161\/STROKEAHA.111.620468","journal-title":"Stroke"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/383125","article-title":"Ketamine infusion associated with improved neurology in a patient with NMDA receptor encephalitis","volume":"2013","author":"MacMahon M","year":"2013","unstructured":"MacMahon M, Naysmith MR, McCallion S, Rhodes J. Ketamine infusion associated with improved neurology in a patient with NMDA receptor encephalitis. Case Rep Crit Care. 2013, 2013:383125. 10.1155\/2013\/383125","journal-title":"Case Rep Crit Care"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebr.2019.100326","article-title":"Ketamine use in refractory status epilepticus associated with anti-NMDA receptor antibody encephalitis","volume":"12","author":"Santoro JD","year":"2019","unstructured":"Santoro JD, Filippakis A, Chitnis T. Ketamine use in refractory status epilepticus associated with anti-NMDA receptor antibody encephalitis. Epilepsy Behav Rep. 2019, 12:100326. 10.1016\/j.ebr.2019.100326","journal-title":"Epilepsy Behav Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/104545-ketamine-and-its-emergence-in-the-field-of-neurology","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:36:02Z","timestamp":1707489362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/104545-ketamine-and-its-emergence-in-the-field-of-neurology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.27389","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,28]]}}}